Precision surgery aims to clear dangerous brain bleeds

NCT ID NCT07697742

Not yet recruiting Disease control Sponsor: Dr. Michael D Hill Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study investigates whether a standardized microsurgical procedure can safely and effectively remove large spontaneous brain hemorrhages (bleeds) located near the brain's surface. The procedure uses a microscope and computer guidance to evacuate the clot, with the goal of leaving less than 15cc of blood behind. The study enrolls 27 adults with moderate to severe symptoms and aims to assess feasibility, safety, and how well the surgery clears the bleed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Microsurgical hematoma evacuation
What this could lead to: If successful, this approach could offer a safe and effective way to remove large brain hemorrhages, potentially improving recovery and reducing disability.
What could go wrong: This is a small, early-phase study (27 participants) focused on feasibility and safety, not yet proving benefit. Surgery carries risks like infection, bleeding, or neurological damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates